Vir Biotechnology Inc (VIR) NPV
Share news, reports & tips
28 July 2021 12:32
(Sharecast News) - GlaxoSmithKline has inked a joint procurement deal with Brussels for its Covid-19 treatment Sotrovimab together with its partner Vir Biotechnology.
11 March 2021 08:17
(Sharecast News) - Drug companies GlaxoSmithKline and Vir Biotechnology have been advised to finish a final trial of their Covid-19 drug early due to its "profound efficacy".
17 February 2021 12:02
(Sharecast News) - GlaxoSmithKline and Vir Biotechnology will expand their existing collaboration to include the research and development of new therapies for influenza and other respiratory viruses.
Company announcements Announcements
No company announcements about Vir Biotechnology Inc NPV were found.
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.